... samples, and HH grew the crystals and performed crystallographic analysis. BETand JHE developed the TL-3 inhibitor, and JHE directed the design of the 12X chimeric FIV protease. CDS super-vised the ... Liu F, Kovalevsky AY, Louis JM, Boross PI, Wang Y- F, Harrison RW,Weber IT: "Mechanism of Drug Resistance Revealed by the Crystal Structure of the Unliganded HIV-1 Protease with F53L Mutation". ... purposes)Comparison of the flap regions of wild-type FIV protease, 12X FIV protease, and wild-type HIV proteaseFigure 5Comparison of the flap regions of wild-type FIV protease, 12X FIV protease, and wild-type...